These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5739041)

  • 1. [Influence of gastric mucoprotein on lipemia, cholesteremia and plasma clearing in school-age children].
    Buda D; Vermiglia L; Minicuci P
    Minerva Pediatr; 1968 Apr; 20(14):787-91. PubMed ID: 5739041
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of blood crasis, cholesteremia, lipemia and glycemia in rabbits exposed to treatment with gastric mucoprotein and vaccinated. I].
    Alosi C; Londrillo A; Mazzaglia E
    Arch Sci Med (Torino); 1968 Jan; 125(1):1-6. PubMed ID: 4878152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Statistical evaluation of the values of cholesteremia in subjects fed various types of milk].
    Caruso P; Ciliberto R
    Minerva Pediatr; 1970 Jan; 22():Suppl 4:23-5. PubMed ID: 5467596
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
    Antikainen M; Holmberg C; Taskinen MR
    Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLASMA clearing effects of gastric mucin.
    Nutr Rev; 1959 Sep; 17():265-6. PubMed ID: 13858062
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma-clearing effect of gastric mucin in healthy and atherosclerotic subjects under basal conditions.
    ROSSI B; RULLI V
    Circulation; 1958 Sep; 18(3):397-9. PubMed ID: 13573560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of gastric mucoprotein on humoral changes in arteriosclerosis].
    PIANIGIANI A; RICCARDI R
    Riforma Med; 1960 Jun; 74():629-33. PubMed ID: 13735367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of simfibrate on post-heparin lipoprotein lipase].
    Cavallini L; Lucchetti G; Marchi S; Guglielmini R
    Clin Ter; 1980 Jan; 92(1):25-31. PubMed ID: 7004746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research on experimental hyperlipemia. IV. Effects of heparin on the inhibitor of the clarifying factor].
    Jouzier E; Tixier M; Tayeau F
    Bord Med; 1970 Sep; 3(9):2017-20. PubMed ID: 5481185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental and clinical studies with a lipotropic gastric mucoprotein].
    CAPRARO V; GOLDECK H
    Gazz Med Ital; 1960 Feb; 119():85-8. PubMed ID: 13807570
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antilipemic action of a mucin preparation from the gastric mucosa of the sow in rabbits under high cholesterol diet].
    CANTONE A
    Boll Soc Ital Biol Sper; 1955; 31(7-8):838-40. PubMed ID: 13315694
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alimentary lipemia and post-heparin lipoprotein lipase activity (PHLA) in children with dysthyroidism].
    Szczepski O; Walczak M; Korman E; Rakowska E; Rakowski W; Socha J
    Endokrynol Pol; 1974; 25(3):205-10. PubMed ID: 4844987
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma turbidity changes and electrocardiographic alterations induced by alimentary hyperlipemia in anginal patients before and after the administration of gastric mucin.
    RULLI V; ROSSI B
    Circulation; 1958 Sep; 18(3):400-4. PubMed ID: 13573561
    [No Abstract]   [Full Text] [Related]  

  • 14. Interrelationships between nutrient intake and plasma lipids and lipoproteins in schoolchildren aged 6 to 19: the Princeton School District Study.
    Morrison JA; Larsen R; Glatfelter L; Boggs D; Burton K; Smith C; Kelly K; Mellies MJ; Khoury P; Glueck CJ
    Pediatrics; 1980 Apr; 65(4):727-34. PubMed ID: 7367079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sotalol withdrawal on serum lipids and lipoprotein lipase activity.
    Lehtonen A; Hietanen E; Marniemi J; Peltonen P; Nikkilä EA
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):73-6. PubMed ID: 6840928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastric mucoprotein as a hepatoprotective factor in infantile icterogenic hepatitis].
    Londrillo A; Buda D
    Minerva Pediatr; 1968 Apr; 20(14):792-6. PubMed ID: 5739042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hyperlipemia & certain clearing factors on erythrosedimentation rate in autoplasma & in pectin in atherosclerotic subjects].
    RULLI V; ROSSI B
    Gazz Med Ital; 1959 May; 118(5):207-10. PubMed ID: 13664061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of total lipemia, cholesteremia and lipoprotein fractions in the postoperative period in children].
    Giugiaro A; Ponzone A; Baratono S
    Minerva Pediatr; 1966 Feb; 18(6):262-9. PubMed ID: 5930937
    [No Abstract]   [Full Text] [Related]  

  • 19. The three main components of the human gastric mucin; dissolved mucoproteose, dissolved mucoprotein, and mucoid of the gastric visible mucus; preliminary data on physiological and clinical significance of separate quantitative determination of the dissolved mucoproteose and dissolved mucoprotein in the gastric juice of man.
    GLASS GB; BOYD LJ
    Gastroenterology; 1949 May; 12(5):849-78. PubMed ID: 18128424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipemia clearing action of a gastric mucin preparation].
    CUCURACHI L; DETTORI AG
    Minerva Med; 1957 Dec; 48(103):4503-12. PubMed ID: 13516717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.